These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2869240)

  • 1. Long-term frozen sera for epidemiological studies of antibodies.
    Torfs CP; van der Berg BJ; Sever JL; Okerlund MD
    Lancet; 1986 Mar; 1(8479):503-4. PubMed ID: 2869240
    [No Abstract]   [Full Text] [Related]  

  • 2. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid antibodies in Graves' disease. An immunofluorescence study.
    Szabó J; Leövey A
    Acta Med Hung; 1983; 40(2-3):91-7. PubMed ID: 6366729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal functions in Graves' disease with special reference to thyroid antibodies.
    Rao PS; Gupta PS; Rao B; Ghosh BK; Prakash P; Misra RC
    Indian J Med Res; 1981 Jan; 73():96-100. PubMed ID: 6894585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of thyroid autoimmunity in man. Contribution of cell cultures to the study of antibodies stimulating the thyroid gland in Basedow's disease].
    Yeni P; Pautard B; Charreire J
    Presse Med; 1983 Oct; 12(38):2383-7. PubMed ID: 6314325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
    Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-FucGM1 antibody in sera from patients with Graves' disease detected by enzyme-linked immunosorbent assay].
    Sawada K; Imura H; Sakurami T; Iwamori M; Nagai Y
    Arerugi; 1982 Oct; 31(10):1041-7. PubMed ID: 6897763
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.
    Cho WY; Choi HH; Chun HJ; Ahn IM
    Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of circulating immune complexes in Graves' disease by the Raji cell technique and their relation to different thyroid autoantibodies.
    Hopf U; Hütteroth TH; Kotulla P
    Horm Metab Res; 1979 Nov; 11(11):622-8. PubMed ID: 231561
    [No Abstract]   [Full Text] [Related]  

  • 10. Islet cell surface antibodies in Graves' disease; as organ non-specific antibodies.
    Ahn IM; Izumi M; Nagataki S
    Korean J Intern Med; 1988 Jan; 3(1):38-44. PubMed ID: 3153792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Method of determining autoantibodies to thyroid antigens in diffuse toxic goiter and Hashimoto's thyroiditis].
    Aleksandrova GF; Vnotchenko SL; Konnova EV; Iur'eva NP
    Sov Med; 1981; (5):36-9. PubMed ID: 7022680
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive value of thyroid autoantibodies in the follow up of drug treated Graves' hyperthyroidism.
    Hampel R; Meng W; Meng S; Krabbe S; Ventz M; Männchen E; Kirsch G
    Radiobiol Radiother (Berl); 1987; 28(5):612-4. PubMed ID: 3441609
    [No Abstract]   [Full Text] [Related]  

  • 13. [Membrane and thyroglobulin antibodies in Graves-Basedow disease treated with I-131 or thyrostatics].
    Czech W; Krzaścik E; Gardas A; Jastrzebska H; Bednarski A
    Pol Tyg Lek; 1986 Feb; 41(5):142-4. PubMed ID: 2423993
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid-stimulating antibody in Graves' disease.
    Davies TF
    Lancet; 1984 Jun; 1(8391):1417-8. PubMed ID: 6145871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Frequency of autoimmune reactions in diffuse toxic goiter].
    Mazepa MA; Parashchak AP
    Vrach Delo; 1976 Jan; (1):107-10. PubMed ID: 946134
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
    Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
    [No Abstract]   [Full Text] [Related]  

  • 17. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
    Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of radioimmunoassay with enzyme-immunoassay and other methods for thyroid antimicrosomal antibodies determination.
    Lacka K; Kosowicz J; Gembicki M; Gardas A
    Radiobiol Radiother (Berl); 1987; 28(5):604-7. PubMed ID: 3327094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative usefulness of radioimmunological and immunofluorescent methods for detection of thyroid antimicrosomal antibodies].
    Lacka K; Jarczewska K; Kosowicz J; Gembicki M
    Pol Tyg Lek; 1985 Jul; 40(27):763-6. PubMed ID: 3900958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.